ArticleHeliyon2024

Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: A retrospective cohort study.

Peng Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.